Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Non-Current Deferred Tax Liability (2021 - 2025)

Climb Bio filings provide 3 years of Non-Current Deferred Tax Liability readings, the most recent being -$15000.0 for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 157.69% to -$15000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$15000.0 through Dec 2025, down 157.69% year-over-year, with the annual reading at -$15000.0 for FY2025, 157.69% down from the prior year.
  • Non-Current Deferred Tax Liability hit -$15000.0 in Q4 2025 for Climb Bio, down from $26000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $26000.0 in Q4 2024 and bottomed at -$15000.0 in Q4 2025.
  • Average Non-Current Deferred Tax Liability over 3 years is $0.0, with a median of -$11000.0 recorded in 2021.
  • Peak annual rise in Non-Current Deferred Tax Liability hit 157.69% in 2025, while the deepest fall reached 157.69% in 2025.
  • Climb Bio's Non-Current Deferred Tax Liability stood at -$11000.0 in 2021, then surged by 336.36% to $26000.0 in 2024, then plummeted by 157.69% to -$15000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLYM's Non-Current Deferred Tax Liability are -$15000.0 (Q4 2025), $26000.0 (Q4 2024), and -$11000.0 (Q4 2021).